-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Compass Therapeutics with Overweight Rating

Benzinga·12/03/2025 16:11:12
Listen to the news
Cantor Fitzgerald analyst Li Watsek initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Overweight rating.